Enzon and Viskase amend merger agreement terms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Enzon and Viskase Announce Amendment to Merger Agreement
October 24, 2025 4:50 PM EDTCRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (Enzon or the Company) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (Viskase) today announced that they have entered into an amendment (the Amendment) to the previously disclosed Agreement and Plan of Merger (the Merger Agreement), pursuant to which Viskase will merge with and into a wholly owned subsidiary of Enzon in an all-stock transaction (the Merger). The Amendment was entered into to reflect recent developments in the operations of Viskase during the past several... More
